Author: Site Editor Publish Time: 09-11-2026 Origin: Site
Across the spectrum of injectable treatments—ranging from dermal fillers to skin rejuvenation—you may have noticed the frequent appearance of one particular ingredient: hyaluronic acid (HA).
However, not all hyaluronic acid products are alike. Specifically, cross-linked and non-cross-linked HA differ significantly in their physical properties, functions, and clinical applications.
Therefore, for clinics and professional practices aiming to improve skin quality through skin booster treatments, it is crucial to understand the characteristics of non-cross-linked HA skin booster , how to select the right product, and the distinctions between different products.
Hyaluronic acid (HA) skin boosters are injectable treatments designed primarily to improve skin quality rather than restore facial volume. Unlike cross-linked HA fillers used for structural support, non-cross-linked HA focuses on hydration, elasticity, and overall skin condition.
Just a difference in the degree of cross-linking leads to significant differences in the properties, applications, and other aspects of these two hyaluronic acid skin boosters.
Comparison | Non Cross Linked HA | Cross-Linked HA |
Molecular structure | Mainly linear HA chains | HA chains connected through cross-linking |
Physical properties | More fluid, lower viscosity | More cohesive, gel-like |
Main use | Hydration and skin-quality improvement | Volume correction and contouring |
Treatment goal | Skin rejuvenation and skin condition | Facial shaping and wrinkle correction |
Common areas | Face, neck, hands, décolletage | Cheeks, nasolabial folds, chin, etc. |
Persistence | Generally shorter; often used in courses | Generally longer-lasting |
When choosing a non-cross-linked hyaluronic acid skin booster, focus on the following key factors:
Concentration and molecular weight. Concentration directly affects hydration, while molecular weight also influences skin quality improvement. High-molecular-weight HA provides structural support, while low-molecular-weight HA helps with penetration and hydration. Some products combine both for dual benefits. Prejuva® contains 64 mg of HA per 2 mL, with equal amounts of high- and low-molecular-weight HA, while Mesocel® HA contains 20 mg/mL of non-cross-linked HA with added nutrients for basic hydration and daily skin care.
Stabilization technology. Non-cross-linked HA is more easily degraded and has a relatively shorter duration. If longer-lasting and more stable improvement is desired, consider products using non-chemical stabilization technologies, such as thermal fusion or lactonization. Prejuva® uses patented HylaFuse™ thermal treatment technology to promote a synergistic structure between high- and low-molecular-weight HA, allowing a higher HA concentration without increasing viscosity, while contributing to more stable and longer-lasting skin improvement.
Compatibility with treatment devices. Some non-cross-linked products can be used with mesotherapy guns or microneedling devices. Before purchasing, confirm compatibility with your clinic’s existing equipment.
Regulatory compliance. For distributors, check the product’s registration status, relevant certifications, and supply stability. Dermax develops advanced non-cross-linked HA skin boosters and provides professional partners with compliant product documentation and stable supply. NutriDerm® Skin Booster offers a multi-ingredient HA formulation for clinics and distributors looking to expand their product range.
Treatment goals and product selection. When the main treatment goals are hydration, enhanced elasticity, or broader skin quality improvement, non-cross-linked HA skin boosters may be considered. The specific product should then be selected according to the patient's individual skin needs.
Professional assessment. Patient selection is also particularly important. Before treatment, assess the patient's skin condition, previous treatment history, allergy history, and whether there is any active infection, inflammation, or skin damage. Injection should only be performed after confirming that the patient is suitable for treatment.
Treatment planning. The effects of a single injection are usually difficult to maintain for a long time. A common treatment plan consists of 2–3 treatments at 3–4-week intervals, followed by maintenance treatments every 3–6 months according to the patient's skin condition. The treatment schedule should also be adjusted according to the patient's actual condition and treatment response.
Injection technique. Non-cross-linked products are usually injected into the superficial to mid-dermal layers. For low-viscosity products, small amounts should be injected slowly at multiple points to ensure even distribution.
Aftercare. Mild redness, swelling, bruising, and other symptoms may occur after injection and are generally normal. Patients should avoid strenuous exercise and high-temperature environments for 24 hours. Gentle moisturizing products and strict sun protection are recommended.
Not every patient needs more volume. Sometimes, the better approach is to focus on skin quality itself. That is where non cross linked hyaluronic acid skin boosters have their place.
For clinics and distributors, the key is choosing a formulation that fits the treatment goal and the needs of the product portfolio.
Looking to add non-cross-linked HA to your range? We can provide product details and discuss suitable options for your market.
